• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性心房颤动的临床和实验室生物标志物:一项单中心横断面研究。

Clinical and Laboratory Biomarkers in Paroxysmal Atrial Fibrillation: A Single Center Cross-Sectional Study.

机构信息

Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

Contrast Media Mol Imaging. 2022 Jun 29;2022:7012377. doi: 10.1155/2022/7012377. eCollection 2022.

DOI:10.1155/2022/7012377
PMID:35845733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9259273/
Abstract

The clinical risk profile of paroxysmal atrial fibrillation (pAF) patients is inconclusive. We aimed to identify clinical and laboratory biomarkers in patients with pAF and the differences in biomarkers among genders. A cross-sectional study was conducted with a total of 181 participants in a single center in Beijing Anzhen Hospital. The participants were grouped according to the presence of pAF and sex differences, and clinical and laboratory results were collected and compared. The 181 participants had a mean age of 52.9 ± 15.1 years (pAF group, 60.4 ± 9.9 years, SR group, 48.3 ± 15.9 years,  < 0.05). Patients with pAF had significantly higher rates of age, left atrial (LA) diameter, haemoglobin (Hb) levels, tissue inhibitor of metalloproteinase-1 (TIMP-1), soluble tumour suppressor-2 (sST2), B-type natriuretic peptide (BNP) and indirect bilirubin (Ibil), mean haemoglobin concentration (MCHC), and hypertension (HTN) and smoking ( < 0.05). Multivariable logistic regression analysis revealed that age (OR = 1.075, 95% CI: 1.035-1.118,  < 0.0001), smoking (OR = 4.538, 95% CI: 1.559-13.205,  = 0.006), and MCHC (OR = 1.062, 95% CI: 1.019-1.106,  = 0.004) were independent predictive factors for pAF. Multivariable logistic regression analysis found that age (OR = 1.107, 95% CI: 1.016-1.206,  = 0.02) and Ibil level (OR = 2.303, 95% CI: 1.158-4.582,  = 0.017) were independent predictive factors of the occurrence of pAF in females; BNP (OR = 1.015, 95% CI: 1.002-1.029,  = 0.029) was an independent predictive variable of pAF in males. Age, smoking, and MCHC were independent predictive factors of pAF. BNP was an independent predictive biomarker of pAF in males, while in females, age and Ibil were independent predictive factors.

摘要

阵发性心房颤动(pAF)患者的临床风险特征尚无定论。我们旨在确定 pAF 患者的临床和实验室生物标志物以及不同性别之间生物标志物的差异。这项横断面研究共纳入了北京安贞医院的 181 名参与者。根据是否存在 pAF 和性别差异对参与者进行分组,并收集和比较临床和实验室结果。181 名参与者的平均年龄为 52.9±15.1 岁(pAF 组为 60.4±9.9 岁,SR 组为 48.3±15.9 岁, < 0.05)。pAF 患者的年龄、左心房(LA)直径、血红蛋白(Hb)水平、组织金属蛋白酶抑制剂-1(TIMP-1)、可溶性肿瘤抑制物-2(sST2)、B 型利钠肽(BNP)和间接胆红素(Ibil)、平均血红蛋白浓度(MCHC)、高血压(HTN)和吸烟率明显更高( < 0.05)。多变量逻辑回归分析显示,年龄(OR = 1.075,95%CI:1.035-1.118, < 0.0001)、吸烟(OR = 4.538,95%CI:1.559-13.205, = 0.006)和 MCHC(OR = 1.062,95%CI:1.019-1.106, = 0.004)是 pAF 的独立预测因素。多变量逻辑回归分析发现,年龄(OR = 1.107,95%CI:1.016-1.206, = 0.02)和 Ibil 水平(OR = 2.303,95%CI:1.158-4.582, = 0.017)是女性 pAF 发生的独立预测因素;BNP(OR = 1.015,95%CI:1.002-1.029, = 0.029)是男性 pAF 的独立预测变量。年龄、吸烟和 MCHC 是 pAF 的独立预测因素。BNP 是男性 pAF 的独立预测生物标志物,而女性中,年龄和 Ibil 是独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa7/9259273/847a9c1a03ce/CMMI2022-7012377.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa7/9259273/847a9c1a03ce/CMMI2022-7012377.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa7/9259273/847a9c1a03ce/CMMI2022-7012377.001.jpg

相似文献

1
Clinical and Laboratory Biomarkers in Paroxysmal Atrial Fibrillation: A Single Center Cross-Sectional Study.阵发性心房颤动的临床和实验室生物标志物:一项单中心横断面研究。
Contrast Media Mol Imaging. 2022 Jun 29;2022:7012377. doi: 10.1155/2022/7012377. eCollection 2022.
2
Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1.可溶性肿瘤抑制因子 2 蛋白和组织基质金属蛋白酶抑制剂 1 预测心房颤动发生和进展的生物标志物。
Int J Clin Pract. 2022 Dec 31;2022:6926510. doi: 10.1155/2022/6926510. eCollection 2022.
3
Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.多普勒衍生指数和B型利钠肽预测原发性高血压患者阵发性心房颤动:一项前瞻性研究。
Echocardiography. 2007 Oct;24(9):911-22. doi: 10.1111/j.1540-8175.2007.00493.x.
4
Impact of Atrial Natriuretic Peptide Value for Predicting Paroxysmal Atrial Fibrillation in Ischemic Stroke Patients.心房利钠肽值对预测缺血性中风患者阵发性心房颤动的影响。
J Stroke Cerebrovasc Dis. 2017 Apr;26(4):772-778. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.016. Epub 2016 Nov 18.
5
Functional studies of left atrium and BNP in patients with paroxysmal atrial fibrillation and the prediction of recurrence after CPVA.阵发性心房颤动患者左心房及脑钠肽的功能研究与导管消融术后复发的预测
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4997-5007. doi: 10.26355/eurrev_202005_21191.
6
Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.B型利钠肽水平在接受肺静脉隔离术的阵发性和持续性心房颤动患者中的预测价值
J Interv Card Electrophysiol. 2011 Apr;30(3):217-25. doi: 10.1007/s10840-010-9540-2. Epub 2011 Jan 20.
7
A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score.一种预测急性卒中患者阵发性心房颤动的评分:iPAB评分。
J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2263-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.019. Epub 2015 Jul 17.
8
Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation.在阵发性心房颤动患者中,增强指数与B型利钠肽相关。
Hypertens Res. 2009 Jul;32(7):611-6. doi: 10.1038/hr.2009.62. Epub 2009 May 1.
9
Prevalence and Risk Factors for Paroxysmal Atrial Fibrillation and Flutter Detection after Cryptogenic Ischemic Stroke.隐源性缺血性卒中后阵发性心房颤动和心房扑动检测的患病率及危险因素
J Stroke Cerebrovasc Dis. 2018 Jan;27(1):203-209. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.022. Epub 2017 Oct 9.
10
Demographic and Clinical Characteristics to Predict Paroxysmal Atrial Fibrillation: Insights from an Implantable Loop Recorder Population.预测阵发性心房颤动的人口统计学和临床特征:来自植入式循环记录仪人群的见解。
Pacing Clin Electrophysiol. 2015 Oct;38(10):1217-22. doi: 10.1111/pace.12692. Epub 2015 Aug 18.

引用本文的文献

1
regulation of cardiac fibroblast proliferation via the TGF-β/Smad pathway in an model of atrial fibrillation.通过转化生长因子-β/ Smad 信号通路对心房颤动模型中心脏成纤维细胞增殖的调控
J Thorac Dis. 2025 Jun 30;17(6):4249-4263. doi: 10.21037/jtd-2025-1088. Epub 2025 Jun 26.
2
Relationship between elevated serum direct bilirubin and atrial fibrillation risk among patients with coronary artery disease.冠心病患者血清直接胆红素升高与心房颤动风险之间的关系。
Front Med (Lausanne). 2025 Feb 14;12:1405682. doi: 10.3389/fmed.2025.1405682. eCollection 2025.
3
Development and trends in research on hypertension and atrial fibrillation: A bibliometric analysis from 2003 to 2022.

本文引用的文献

1
Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.心血管磁共振测定的左心室心肌损伤与阵发性心房颤动患者的 C 反应蛋白和 ST2 相关。
J Cardiovasc Magn Reson. 2021 Mar 22;23(1):30. doi: 10.1186/s12968-021-00732-5.
2
Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.血清可溶性 ST2 是评估阵发性心房颤动左心房低电压区的新型生物标志物。
Med Sci Monit. 2020 Sep 8;26:e926221. doi: 10.12659/MSM.926221.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
高血压与心房颤动的研究进展与趋势:2003 年至 2022 年的文献计量分析。
Medicine (Baltimore). 2024 May 24;103(21):e38264. doi: 10.1097/MD.0000000000038264.
4
Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis.可溶性肿瘤形成抑制因子2在心房颤动中的预测价值:一项系统评价和荟萃分析
Front Cardiovasc Med. 2024 Jan 11;10:1308166. doi: 10.3389/fcvm.2023.1308166. eCollection 2023.
5
Association Between Serum Bilirubin and Atrial Fibrillation: A Mendelian Randomization Study.血清胆红素与心房颤动之间的关联:一项孟德尔随机化研究。
Korean Circ J. 2023 Jul;53(7):472-479. doi: 10.4070/kcj.2023.0003. Epub 2023 Apr 19.
2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Functional studies of left atrium and BNP in patients with paroxysmal atrial fibrillation and the prediction of recurrence after CPVA.阵发性心房颤动患者左心房及脑钠肽的功能研究与导管消融术后复发的预测
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4997-5007. doi: 10.26355/eurrev_202005_21191.
5
A link between bilirubin levels and atrial fibrillation recurrence after catheter ablation.胆红素水平与导管消融后心房颤动复发之间的联系。
J Chin Med Assoc. 2019 Mar;82(3):175-178. doi: 10.1097/JCMA.0000000000000026.
6
Relative hypochromia and mortality in acute heart failure.相对低色素性与急性心力衰竭患者的死亡率。
Int J Cardiol. 2019 Jul 1;286:104-110. doi: 10.1016/j.ijcard.2019.02.060. Epub 2019 Feb 27.
7
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
8
Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation.纤维化标志物可溶性ST2可预测非瓣膜性阵发性心房颤动冷冻球囊导管消融术后心房颤动复发
Korean Circ J. 2018 Oct;48(10):920-929. doi: 10.4070/kcj.2018.0047.
9
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.B 型利钠肽在心房颤动中的疾病进展和临床结局。
Heart. 2019 Mar;105(5):370-377. doi: 10.1136/heartjnl-2018-313642. Epub 2018 Sep 18.
10
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.根据最佳、临界或升高水平的危险因素,预测心房颤动的终生风险:基于弗雷明汉心脏研究纵向数据的队列研究。
BMJ. 2018 Apr 26;361:k1453. doi: 10.1136/bmj.k1453.